Lumata Health: A Vision for the Future of Eye Care
March 7, 2025, 9:36 pm
Location: United States, Oklahoma, Oklahoma City
Employees: 11-50
Founded date: 2017
Total raised: $27M
In a world where sight is often taken for granted, Lumata Health is stepping up to change the narrative. The Oklahoma City-based company recently secured $23 million in Series B funding, bringing its total capital raised to $36 million. This financial boost is not just a number; it represents a lifeline for millions at risk of preventable vision loss.
The funding round was co-led by LRVHealth, McKesson Ventures, and Cencora Ventures, with support from existing investors like Cortado Ventures. This backing underscores a growing recognition of the urgent need for innovative solutions in eye care. As chronic eye diseases like glaucoma and diabetic retinopathy become more prevalent, Lumata is poised to make a significant impact.
Vision loss is not just a personal tragedy; it’s a public health crisis. The number of people affected by sight-threatening conditions is expected to double in the coming decades. Despite the existence of effective treatments, many patients face systemic barriers that delay or prevent timely care. Lumata Health aims to dismantle these barriers with a data-driven approach that combines predictive analytics and personalized interventions.
Imagine a world where every patient receives tailored support, ensuring they adhere to their treatment plans. Lumata’s platform is designed to do just that. Studies indicate that for every 1,000 patients engaged with Lumata, an additional 800 vision-saving eye injections are administered annually. This proactive model not only preserves sight but also reduces long-term healthcare costs associated with vision loss. It’s a win-win scenario, akin to planting seeds today for a bountiful harvest tomorrow.
Founded in 2017 by Dr. Stephen Fransen, an ophthalmologist with over three decades of experience, Lumata Health is led by CEO Landon Grace. The company employs hundreds of certified ophthalmic care coaches, data scientists, and healthcare executives, all united by a common goal: to end preventable blindness. Their human-led, technology-driven care management platform partners with physicians, payers, and pharmaceutical manufacturers to deliver tailored interventions. This collaboration enhances clinical outcomes and patient satisfaction while generating additional revenue and reducing downstream healthcare costs.
The recent funding will enable Lumata to expand its operations and enhance its technology. The goal is clear: to meet the growing demand for vision-saving care. The company’s innovative approach has already garnered attention from major eye care providers across the country, including the five largest national and regional networks. These partnerships have driven rapid growth and demonstrated Lumata’s effectiveness in improving treatment adherence and patient satisfaction.
In the realm of healthcare, the stakes are high. Vision loss can lead to a cascade of complications, affecting not just the individual but also families and communities. The emotional toll is immense. Lumata Health understands this and is committed to reshaping how chronic eye diseases are managed. By leveraging advanced technology and compassionate care, the company is ensuring that more patients retain their vision for years to come.
The implications of Lumata’s work extend beyond individual patients. As more specialty medicines enter the market, solutions that help patients start and stay on their prescribed treatment regimens become increasingly vital. Lumata’s blend of technology and tailored support fosters greater patient engagement and adherence to treatment plans. This is not just about saving sight; it’s about improving lives.
Investors are taking notice. The healthcare landscape is shifting, and companies like Lumata Health are at the forefront of this change. The potential to reduce overall healthcare costs while generating significant value for ophthalmology practices is a compelling proposition. Lumata’s proactive, end-to-end solution not only improves patient outcomes but also creates a sustainable model for care.
As Lumata Health embarks on this new chapter, the focus remains on the patient. Every decision, every innovation, is driven by the desire to enhance patient care. The journey is just beginning, but the vision is clear. With the right support and a commitment to excellence, Lumata Health is on a path to transform the future of eye care.
In conclusion, Lumata Health is not just a company; it’s a beacon of hope for those at risk of vision loss. The recent funding marks a significant milestone in its mission to eliminate preventable blindness. As the company continues to grow and innovate, it stands as a testament to what can be achieved when technology and compassion come together. The future looks bright, and for millions, it’s a future filled with vision.
The funding round was co-led by LRVHealth, McKesson Ventures, and Cencora Ventures, with support from existing investors like Cortado Ventures. This backing underscores a growing recognition of the urgent need for innovative solutions in eye care. As chronic eye diseases like glaucoma and diabetic retinopathy become more prevalent, Lumata is poised to make a significant impact.
Vision loss is not just a personal tragedy; it’s a public health crisis. The number of people affected by sight-threatening conditions is expected to double in the coming decades. Despite the existence of effective treatments, many patients face systemic barriers that delay or prevent timely care. Lumata Health aims to dismantle these barriers with a data-driven approach that combines predictive analytics and personalized interventions.
Imagine a world where every patient receives tailored support, ensuring they adhere to their treatment plans. Lumata’s platform is designed to do just that. Studies indicate that for every 1,000 patients engaged with Lumata, an additional 800 vision-saving eye injections are administered annually. This proactive model not only preserves sight but also reduces long-term healthcare costs associated with vision loss. It’s a win-win scenario, akin to planting seeds today for a bountiful harvest tomorrow.
Founded in 2017 by Dr. Stephen Fransen, an ophthalmologist with over three decades of experience, Lumata Health is led by CEO Landon Grace. The company employs hundreds of certified ophthalmic care coaches, data scientists, and healthcare executives, all united by a common goal: to end preventable blindness. Their human-led, technology-driven care management platform partners with physicians, payers, and pharmaceutical manufacturers to deliver tailored interventions. This collaboration enhances clinical outcomes and patient satisfaction while generating additional revenue and reducing downstream healthcare costs.
The recent funding will enable Lumata to expand its operations and enhance its technology. The goal is clear: to meet the growing demand for vision-saving care. The company’s innovative approach has already garnered attention from major eye care providers across the country, including the five largest national and regional networks. These partnerships have driven rapid growth and demonstrated Lumata’s effectiveness in improving treatment adherence and patient satisfaction.
In the realm of healthcare, the stakes are high. Vision loss can lead to a cascade of complications, affecting not just the individual but also families and communities. The emotional toll is immense. Lumata Health understands this and is committed to reshaping how chronic eye diseases are managed. By leveraging advanced technology and compassionate care, the company is ensuring that more patients retain their vision for years to come.
The implications of Lumata’s work extend beyond individual patients. As more specialty medicines enter the market, solutions that help patients start and stay on their prescribed treatment regimens become increasingly vital. Lumata’s blend of technology and tailored support fosters greater patient engagement and adherence to treatment plans. This is not just about saving sight; it’s about improving lives.
Investors are taking notice. The healthcare landscape is shifting, and companies like Lumata Health are at the forefront of this change. The potential to reduce overall healthcare costs while generating significant value for ophthalmology practices is a compelling proposition. Lumata’s proactive, end-to-end solution not only improves patient outcomes but also creates a sustainable model for care.
As Lumata Health embarks on this new chapter, the focus remains on the patient. Every decision, every innovation, is driven by the desire to enhance patient care. The journey is just beginning, but the vision is clear. With the right support and a commitment to excellence, Lumata Health is on a path to transform the future of eye care.
In conclusion, Lumata Health is not just a company; it’s a beacon of hope for those at risk of vision loss. The recent funding marks a significant milestone in its mission to eliminate preventable blindness. As the company continues to grow and innovate, it stands as a testament to what can be achieved when technology and compassion come together. The future looks bright, and for millions, it’s a future filled with vision.